Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community

Table 1 Baseline characteristics of the study participants

Subject characteristics	N = 103 (%)
Age, mean ± SD, years	78.19 ± 6.87
Male sex	31 (29.66)
Literate	83 (80.58)
Live alone	37 (35.92)
Smoking
Never	80(77.67)
Quitted	19(18.45)
Current	2(1.94)
Unknown	2(1.94)
Exercise Habit
Amount per week,mean ± SD, minutes	243.43 ± 202,19
- Less than 150 min per day	36(34.95)
− 150 min or above	62 (60.19)
- Unknown	5 (4.85)
Disease Status at baseline visit
Uncontrolled blood pressure level	57 (55.34)
- Stage II Hypertension^a	19/57 (33.33)
Uncontrolled RCBG level^b	20(19.42)
Uncontrolled cholesterol levels	56(54.37)
- Uncontrolled LDL-C level^c	21/56(37.50)
- Uncontrolled TG level^d	46/56 (82.14)
- Both uncontrolled LDL-C and TG levels	11/56(19.64)
Present with symptoms of heart failure corresponding to NYIIA Functional Classification system	87 (84.47)
Medical history
Hypertension	97 (94.17)
Diabetes mellitus	44 (42.72)
Hyperlipidemia	76(73.79)
Coronary Heart Disease	20(19.42)
Heart failure	4(3.88)
Stroke	13(12.62)
Medications
Number of chronic medications, mean ± SD	5.08 ± 3.02

a: Non-stage II - Systolic blood pressure < 160mmHg Or Diastolic blood pressure < 100mmHg
Stage II - Systolic blood pressure≧160mmHg Or Diastolic blood pressure≧100mmHg (JNC 7 Guideline [13])
b: Uncontrolled RCBG level: ≥ 11.1 mmol/L (ADA [14])
c: Uncontrolled LDL-C level: ≥ 2.59 mmol/L (ATP III [15])
d: Uncontrolled TG level : ≥ 2.3mmol/L (ATP III [15])

ISSN: 1471-2261